Ask Warren

Osteonic

226400 · KOSDAQ · ₩226400 · 오스테오닉

₩4,060▼ ₩15 (0.37%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩13B₩13B₩13B₩12B₩11B₩9.5B₩9.7B₩8.2B
Cost of sales₩7.1B₩6.3B₩6.7B₩6.2B₩5.8B₩4.7B₩4.5B₩4.6B
Gross profit₩6.1B₩6.6B₩6.3B₩5.7B₩5.2B₩4.9B₩5.2B₩3.6B
Operating income₩2.4B₩2.3B₩2.4B₩2.2B₩2.7B₩1.5B₩2.3B₩1.6B
Net income−₩838M₩2.7B₩5.5B₩980M₩247M₩762M₩4.4B−₩378M
Net income to shareholders₩1.8B₩2.7B₩3.7B₩2B₩1B₩762M₩2.7B₩1.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩114B₩111B₩100B₩96B₩94B₩92B₩90B₩87B
Current assets₩63B₩62B₩59B₩56B₩54B₩52B₩54B₩50B
Cash and equivalents₩14B₩14B₩14B₩13B₩11B₩10B₩10B₩10B
Total liabilities₩42B₩41B₩33B₩32B₩32B₩31B₩31B₩30B
Current liabilities₩28B₩28B₩20B₩19B₩18B₩18B₩17B₩17B
Borrowings₩24B₩24B₩18B₩18B₩15B₩17B₩15B₩15B
Total equity₩72B₩70B₩68B₩64B₩62B₩61B₩59B₩57B
Shareholders' equity₩72B₩70B₩67B₩64B₩62B₩61B₩59B₩57B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩2.8B₩1.6B₩5.2B₩1.1B₩1.6B₩1.1B₩953M₩2.1B
Capital spending₩1B₩7.1B₩1.7B₩1.5B₩655M₩4.9B₩574M₩0
Free cash flow₩1.8B−₩5.5B₩3.5B−₩416M₩988M−₩3.8B₩379M₩2.1B

Consolidated where available. Amounts in won.

Also known as: Osteonic / 오스테오닉 / 226400 / KRX:226400

Source: KRX statistical information